1. The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction

   van der Leest, P. & Schuuring, E., Mar-2020, In : Molecular oncology. 14, 3, p. 487-489 3 p.

   Research output: Contribution to journal › Editorial › Academic › peer-review

2. The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction

   van der Leest, P. & Schuuring, E., 4-Feb-2020, In : Molecular oncology.

   Research output: Contribution to journal › Article › Academic

3. The dual role of the X-linked FoxP3 gene in human cancers

   Redpath, M., Xu, B., van Kempen, L. C. & Spatz, A., Apr-2011, In : Molecular oncology. 5, 2, p. 156-63 8 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. Critical appraisal of quantitative PCR results in colorectal cancer research: can we rely on published qPCR results?

   Dijkstra, J. R., van Kempen, L. C., Nagtegaal, I. D. & Bustin, S. A., Jun-2014, In : Molecular oncology. 8, 4, p. 813-8 6 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. The validity of circulating microRNAs in oncology: five years of challenges and contradictions

   Jarry, J., Schadendorf, D., Greenwood, C., Spatz, A. & van Kempen, L. C., Jun-2014, In : Molecular oncology. 8, 4, p. 819-29 11 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

View all (13) »